Literature DB >> 30517595

Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease.

Catherine A Sumida1, Emily J Van Etten2, Francesca V Lopez3, David P Sheppard4, Eva Pirogovsky-Turk5, Jody Corey-Bloom6, J Vincent Filoteo5,6, Steven P Woods4, Paul E Gilbert7, Maureen Schmitter-Edgecombe1.   

Abstract

OBJECTIVE: Although medication management is a necessary daily activity for individuals with Huntington's disease (HD), medication management abilities and their relation to cognitive functioning have not been evaluated.
METHOD: Twenty individuals with HD and 20 healthy adults (HA) completed the Medication Management Abilities Assessment (MMAA). Individuals with HD also completed a self-report medication management measure and neuropsychological tests assessing executive function, retrospective memory, and prospective memory.
RESULTS: Individuals with HD performed significantly poorer and made more undertaking errors on the MMAA as compared to HA. No group differences were found in overtaking errors. In the HD group, significant associations were found between undertaking errors and perceived medication management ability as well as between MMAA task performance and measures assessing prospective memory and executive functions.
CONCLUSIONS: Medication management capacity was negatively affected in individuals with HD and may be associated with difficulty remembering to take medications in the future.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Everyday functioning; Executive functioning; Huntington’s disease; Learning and memory

Mesh:

Year:  2019        PMID: 30517595      PMCID: PMC6849462          DOI: 10.1093/arclin/acy093

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  13 in total

1.  Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities.

Authors:  Karin F Hoth; Jane S Paulsen; David J Moser; Daniel Tranel; Lee Anna Clark; Antoine Bechara
Journal:  J Clin Exp Neuropsychol       Date:  2007-05       Impact factor: 2.475

2.  Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.

Authors:  Eva Pirogovsky; Dawn M Schiehser; Kristalyn M Obtera; Mathes M Burke; Stephanie L Lessig; David D Song; Irene Litvan; J Vincent Filoteo
Journal:  Neuropsychology       Date:  2014-01-13       Impact factor: 3.295

3.  "Forgetting to remember" in Huntington's disease: a study of laboratory, semi-naturalistic, and self-perceptions of prospective memory.

Authors:  Diane R Nicoll; Eva Pirogovsky; Steven Paul Woods; Heather M Holden; J Vincent Filoteo; Shea Gluhm; Jody Corey-Bloom; Paul E Gilbert
Journal:  J Int Neuropsychol Soc       Date:  2013-12-19       Impact factor: 2.892

Review 4.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

5.  Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.

Authors:  Thomas L Patterson; Jonathan Lacro; Christine L McKibbin; Sherry Moscona; Troy Hughs; Dilip V Jeste
Journal:  J Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.153

6.  Medication Management Performance and Associated Cognitive Correlates in Healthy Older Adults and Older Adults with aMCI.

Authors:  Catherine A Sumida; Thao T Vo; Emily J Van Etten; Maureen Schmitter-Edgecombe
Journal:  Arch Clin Neuropsychol       Date:  2019-05-01       Impact factor: 2.813

7.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

8.  Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management?

Authors:  Steven Paul Woods; Lisa M Moran; Catherine L Carey; Matthew S Dawson; Jennifer E Iudicello; Sarah Gibson; Igor Grant; J Hampton Atkinson
Journal:  Arch Clin Neuropsychol       Date:  2008-02-19       Impact factor: 2.813

9.  Factors associated with adherence to medication regimens in older primary care patients: the Steel Valley Seniors Survey.

Authors:  Gary P Stoehr; Shu-Ya Lu; Laurie Lavery; Joni Vander Bilt; Judith A Saxton; Chung-Chou H Chang; Mary Ganguli
Journal:  Am J Geriatr Pharmacother       Date:  2008-12

10.  Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment.

Authors:  Maureen Schmitter-Edgecombe; Ellen Woo; David R Greeley
Journal:  Neuropsychology       Date:  2009-03       Impact factor: 3.295

View more
  2 in total

1.  Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment.

Authors:  Betul Sumbul-Sekerci; Hasmet A Hanagasi; Basar Bilgic; Zeynep Tufekcioglu; Hakan Gurvit; Murat Emre
Journal:  Acta Neurol Belg       Date:  2022-03-24       Impact factor: 2.396

Review 2.  Prospective memory impairment in neurological disorders: implications and management.

Authors:  Julie D Henry
Journal:  Nat Rev Neurol       Date:  2021-03-08       Impact factor: 42.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.